Varicose Veins - Phlebitis

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-06-01
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:17

Label at a glance#

ProductVaricose Veins - Phlebitis

Active ingredientMicrurus Corallinus Venom, Crotalus Horridus Horridus Venom, Bryonia Alba Root, Calcium Fluoride, Silybum Marianum Seed, Cholesterol, Cinchona Officinalis Bark, Digitalis, Hamamelis Virginiana Root Bark/stem Bark, Hydrofluoric Acid, Lachesis Muta Venom, Lycopodium Clavatum Spore, Naja Naja Venom, Pulsatilla Vulgaris, Vipera Berus Venom, Zinc, Horse Chestnut, Echinacea, Unspecified

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Varicose Veins - Phlebitis Formulated for symptoms associated with varicose veins, phlebitis, ecchymosis, spider veins and other vascular - related conditions.

DOSAGE & ADMINISTRATION SECTION

Directions: Adults, take 6 pellets orally one to four times daily or as directed by a healthcare professional.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Elaps corallinus 35x, Crotalus horridus 20x, Bryonia 15x, Calc. fluor. 15x, Carduus mar. 15x, Cholesterinum 15x, Cinchona 15x, Digitalis 15x, Hamamelis 15x , Hydrofluoricum acidum 15x, Lachesis 15x, Lycopodium 15x, Naja 15x, Pulsatilla 15x, Vipera berus 15x, Zinc. met. 15x, Aesculus hipp. 8x, Echinacea 8x, Hamamelis 8x, Aesculus hipp. 3x, Echinacea 3x, Hamamelis 3x.

PURPOSE SECTION

ABUSE SECTION

Formulated for symptoms associated with varicose veins, phlebitis, ecchymosis, spider veins and other vascular - related conditions.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55714-4473-1	2020-01-31	C162847	48780-1	9d75b9cf-d4f3-f424-e053-dadaa90a57ce	Varicose Veins - Phlebitis
55714-4473-2	2020-01-31	C162847	48780-1	9d75b9cf-d4f3-f424-e053-dadaa90a57ce	Varicose Veins - Phlebitis

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55714-4473-1	Varicose Veins - Phlebitis	28.35 g in 1 BOTTLE, GLASS	PELLET	28.35		1
55714-4473-2	Varicose Veins - Phlebitis	56.7 g in 1 BOTTLE, GLASS	PELLET	56.7		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55714-4473	VARICOSE VEINS - PHLEBITIS (ELAPS CORALLINUS, CROTALUS HORRIDUS, BRYONIA, CALC. FLUOR., CARDUUS MAR., CHOLESTERINUM, CINCHONA, DIGITALIS, HAMAMELIS, HYDROFLUORICUM ACIDUM, LACHESIS, LYCOPODIUM, NAJA, PULSATILLA, VIPERA BERUS, ZINC. MET., AESCULUS HIPP., ECHINACEA) PELLET [NEWTON LABORATORIES, INC.]	1	Legacy NDC, 2 package rows	20131206_cd7d0707-b043-07e9-5847-98e058cd8990.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Bryonia Alba Root	ACTIVE INGREDIENT	T7J046YI2B	1
Calcium Fluoride	ACTIVE INGREDIENT	O3B55K4YKI	1
Cholesterol	ACTIVE INGREDIENT	97C5T2UQ7J	1
Cinchona Officinalis Bark	ACTIVE INGREDIENT	S003A158SB	1
Crotalus Horridus Horridus Venom	ACTIVE INGREDIENT	YHA2XLJ956	1
Digitalis	ACTIVE INGREDIENT	F1T8QT9U8B	1
Echinacea, Unspecified	ACTIVE INGREDIENT	4N9P6CC1DX	1
Hamamelis Virginiana Root Bark/stem Bark	ACTIVE INGREDIENT	T7S323PKJS	1
Horse Chestnut	ACTIVE INGREDIENT	3C18L6RJAZ	1
Hydrofluoric Acid	ACTIVE INGREDIENT	RGL5YE86CZ	1
Lachesis Muta Venom	ACTIVE INGREDIENT	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE INGREDIENT	C88X29Y479	1
Micrurus Corallinus Venom	ACTIVE INGREDIENT	V0S6H36980	1
Naja Naja Venom	ACTIVE INGREDIENT	ZZ4AG7L7VM	1
Pulsatilla Vulgaris	ACTIVE INGREDIENT	I76KB35JEV	1
Silybum Marianum Seed	ACTIVE INGREDIENT	U946SH95EE	1
Vipera Berus Venom	ACTIVE INGREDIENT	0ORO6NCA4M	1
Zinc	ACTIVE INGREDIENT	J41CSQ7QDS	1
Bryonia Alba Root	ACTIVE MOIETY	T7J046YI2B	1
Cholesterol	ACTIVE MOIETY	97C5T2UQ7J	1
Cinchona Officinalis Bark	ACTIVE MOIETY	S003A158SB	1
Crotalus Horridus Horridus Venom	ACTIVE MOIETY	YHA2XLJ956	1
Digitalis	ACTIVE MOIETY	F1T8QT9U8B	1
Echinacea, Unspecified	ACTIVE MOIETY	4N9P6CC1DX	1
Fluoride Ion	ACTIVE MOIETY	Q80VPU408O	1
Hamamelis Virginiana Root Bark/stem Bark	ACTIVE MOIETY	T7S323PKJS	1
Horse Chestnut	ACTIVE MOIETY	3C18L6RJAZ	1
Lachesis Muta Venom	ACTIVE MOIETY	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE MOIETY	C88X29Y479	1
Micrurus Corallinus Venom	ACTIVE MOIETY	V0S6H36980	1
Naja Naja Venom	ACTIVE MOIETY	ZZ4AG7L7VM	1
Pulsatilla Vulgaris	ACTIVE MOIETY	I76KB35JEV	1
Silybum Marianum Seed	ACTIVE MOIETY	U946SH95EE	1
Vipera Berus Venom	ACTIVE MOIETY	0ORO6NCA4M	1
Zinc	ACTIVE MOIETY	J41CSQ7QDS	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

Varicose Veins - Phlebitis
Elaps corallinus, Crotalus horridus, Bryonia, Calc. fluor., Carduus mar., Cholesterinum, Cinchona, Digitalis, Hamamelis, Hydrofluoricum acidum, Lachesis, Lycopodium, Naja, Pulsatilla, Vipera berus, Zinc. met., Aesculus hipp., Echinacea
Micrurus Corallinus Venom
Crotalus Horridus Horridus Venom
Bryonia Alba Root
Calcium Fluoride
Fluoride Ion
Silybum Marianum Seed
Cholesterol
Cinchona Officinalis Bark
Digitalis
Hamamelis Virginiana Root Bark/stem Bark
Hydrofluoric Acid
Lachesis Muta Venom
Lycopodium Clavatum Spore
Naja Naja Venom
Pulsatilla Vulgaris
Vipera Berus Venom
Zinc
Horse Chestnut
Echinacea, Unspecified
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-4473	55714-4473-1, 55714-4473-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Micrurus Corallinus Venom	V0S6H36980	ACTIB
Crotalus Horridus Horridus Venom	YHA2XLJ956	ACTIB
Bryonia Alba Root	T7J046YI2B	ACTIB
Calcium Fluoride	O3B55K4YKI	ACTIB
Silybum Marianum Seed	U946SH95EE	ACTIB
Cholesterol	97C5T2UQ7J	ACTIB
Cinchona Officinalis Bark	S003A158SB	ACTIB
Digitalis	F1T8QT9U8B	ACTIB
Hamamelis Virginiana Root Bark/stem Bark	T7S323PKJS	ACTIB
Hydrofluoric Acid	RGL5YE86CZ	ACTIM
Lachesis Muta Venom	VSW71SS07I	ACTIB
Lycopodium Clavatum Spore	C88X29Y479	ACTIB
Naja Naja Venom	ZZ4AG7L7VM	ACTIB
Pulsatilla Vulgaris	I76KB35JEV	ACTIB
Vipera Berus Venom	0ORO6NCA4M	ACTIB
Zinc	J41CSQ7QDS	ACTIB
Horse Chestnut	3C18L6RJAZ	ACTIB
Echinacea, Unspecified	4N9P6CC1DX	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
775c0b06-dfcf-dd18-51c2-777863f97abf			cd7d0707-b043-07e9-5847-98e058cd8990	2011-06-01	Warnings	Exact identifier spl id: 775c0b06-dfcf-dd18-51c2-777863f97abf spl set id: cd7d0707-b043-07e9-5847-98e058cd8990

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.